• Monitoring tax legislation.
• Monitoring healthcare legislation. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regard the International Pricing Index (IPI) Model, which would import single-payer government run price controls that limit innovation and patient access to life saving therapies. Support rebate rule to bring down the cost of drug prices. Education regarding the bio-similars market place. Support the increased access to Osteoporosis testing for Medicare. H.R. 3517: "The Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act."

Duration: October 1, 2017 to December 31, 2021

General Issues: Taxation/Internal Revenue Code, Health Issues

Spending: about $730,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2017: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Office of Policy Development, Natl Economic Council (NEC), Treasury - Dept of, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA)